France Bariatric Surgery Market Size (2024 - 2029)

The French bariatric surgery market is projected to experience growth over the forecast period, driven by an increase in obesity and related health conditions such as type-2 diabetes and heart diseases. The market's expansion is further supported by advancements in surgical technologies and a rising preference for minimally invasive procedures. Despite the challenges posed by the COVID-19 pandemic, which temporarily disrupted surgical activities, the market is recovering as restrictions have eased. However, the high cost of bariatric surgeries may pose a barrier to growth.

Market Size of France Bariatric Surgery Industry

France Bariatric Surgery Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2021 - 2022
CAGR 13.20 %

Major Players

France Bariatric Surgery Market Major Players

*Disclaimer: Major Players sorted in no particular order

France Bariatric Surgery Market Analysis

The French bariatric surgery market is expected to register a CAGR of 13.2% over the forecast period. 

The COVID-19 pandemic affected the market studied significantly. The global lockdown measures impacted the diagnostic and surgical industries, which have also decreased public mobility. Owing to the fear of the risk of contamination, several surgeries which were deemed non-urgent were postponed in France during the initial phase of the pandemic. The IFSO in April 2020 recommended that all elective surgical and endoscopic cases for metabolic and bariatric surgery should be postponed during the pandemic period. Thus, the bariatric surgery market was impacted severely during the COVID-19 pandemic. However, with the restrictions lifted when the severity reduced, there was a resumption of bariatric surgeries in France. This considerably impacted the market growth. Hence, owing to the above-mentioned factors, the market studied is recovering from the damage caused by the pandemic and is expected to witness growth over the analysis period.

The key factors propelling the growth of the market studied are the increase in obese patients and the prevalence rate of type-2 diabetes and heart diseases.

Obesity is considered a metabolic dysfunction and is often associated with a wide range of chronic illnesses that create a major healthcare burden. The major diseases caused by obesity include hypertension, Type-2 diabetes dyslipidemia, and other diseases. Therefore, obesity is undoubtedly one of the most common causes of diabetes. As bariatric surgery is one of the most efficient methods to control both, the demand for surgery is increasing in France. For instance, according to an article published by C3 Collaborating for Health in July 2021, around 1 in 7 people in France were obese, accounting for 17% of the total population. More than 8.57 million people in the country were obese in 2020. Thus, the large population affected by obesity in the nation is expected to boost the demand for bariatric surgeries. This is further expected to contribute to the growth of the market studied.

In addition, new technologies in bariatric surgery and the growing demand for minimally invasive surgical procedures are expected to act as key drivers for market growth during the forecast period. Thus, bariatric procedures are expected to increase in France, which may accelerate the market studied. Therefore, owing to an increase in obesity among the target population and the emergence of new technology, among other factors, the market studied is anticipated to witness growth over the forecast period. However, the high cost of the surgeries is predicted to hinder the growth of the market studied.

France Bariatric Surgery Industry Segmentation

As per the scope of the report, bariatric surgery is a medical procedure that aids weight loss by either limiting the capacity of the stomach or the absorption of calories. This involves either open or laparoscopic techniques. 

The French bariatric surgery market is segmented by device (assisting devices (suturing devices, closure devices, stapling devices, trocars, clip appliers, and other assisting devices), implantable devices (gastric bands, electrical stimulation devices, gastric balloons, and other implantable devices) and other devices). The report offers market forecasts and revenues in terms of value in USD million for the above segments.

Device
Assisting Devices
Suturing Device
Closure Device
Stapling Device
Trocars
Clip Appliers
Other Assisting Devices
Implantable Devices
Gastric Bands
Electrical Stimulation Devices
Gastric Balloons
Other Implantable Devices
Other Devices
Need A Different Region Or Segment?
Customize Now

France Bariatric Surgery Market Size Summary

The French bariatric surgery market is poised for significant growth, driven by an increasing prevalence of obesity and related chronic conditions such as type-2 diabetes and heart diseases. The market experienced a setback during the COVID-19 pandemic due to the postponement of non-urgent surgeries and reduced public mobility. However, as restrictions eased, the market began to recover, with a resurgence in bariatric procedures. The demand for these surgeries is further bolstered by advancements in minimally invasive techniques and new technologies, which are expected to enhance surgical outcomes and patient recovery times. Despite the high costs associated with these procedures, the growing need for effective obesity management solutions is anticipated to propel market expansion over the forecast period.

The market landscape is characterized by moderate competition, with key players like Apollo Endosurgery Inc., Ethicon Inc. (Johnson & Johnson), and Medtronic PLC (Covidien PLC) leading innovations in surgical devices. The stapling devices segment is expected to witness robust growth due to their widespread use in bariatric procedures, offering significant weight loss and health improvement benefits. Additionally, the demand for gastric balloon procedures is rising, providing a non-invasive weight-loss option for those unable to achieve significant results through diet and exercise alone. However, the lack of national health service coverage for gastric balloons poses a challenge to segment growth. Ongoing clinical studies and product launches are expected to create further opportunities, supporting the market's upward trajectory in France.

Explore More

France Bariatric Surgery Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increase in Obese Patients

      2. 1.2.2 Government Initiatives to Curb Obesity

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Surgery

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD Million)

    1. 2.1 Device

      1. 2.1.1 Assisting Devices

        1. 2.1.1.1 Suturing Device

        2. 2.1.1.2 Closure Device

        3. 2.1.1.3 Stapling Device

        4. 2.1.1.4 Trocars

        5. 2.1.1.5 Clip Appliers

        6. 2.1.1.6 Other Assisting Devices

      2. 2.1.2 Implantable Devices

        1. 2.1.2.1 Gastric Bands

        2. 2.1.2.2 Electrical Stimulation Devices

        3. 2.1.2.3 Gastric Balloons

        4. 2.1.2.4 Other Implantable Devices

      3. 2.1.3 Other Devices

France Bariatric Surgery Market Size FAQs

The France Bariatric Surgery Market is projected to register a CAGR of 13.20% during the forecast period (2024-2029)

Apollo Endosurgery Inc, Conmed Corporation, Johnson and Johnson (Ethicon Inc), B. Braun SE and Medtronic PLC (Covidien PLC) are the major companies operating in the France Bariatric Surgery Market.

France Bariatric Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)